Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Shady Sayed

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jul 22, 2025
A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs.

Pascal Wang, Rituparno Sen, Frank Buchholz

|Jul 08, 2022
Efficient Correction of Oncogenic KRAS and TP53 Mutations through CRISPR Base Editing.

Shady Sayed, Olga A Sidorova, Alexander Hennig

|Mar 10, 2022
RNAi-Mediated Screen of Primary AML Cells Nominates MDM4 as a Therapeutic Target in NK-AML with <i>DNMT3A</i> Mutations.

Olga Alexandra Sidorova, Shady Sayed, Maciej Paszkowski-Rogacz

Pageof 1

Frequent Collaborators

3 joint publications

Frank Buchholz

1 joint publications

Maciej Paszkowski-Rogacz

1 joint publications

Michael Seifert

1 joint publications

Ingo Roeder

1 joint publications

Christian Thiede

1 joint publications

Martina Augsburg

1 joint publications

Catherine P Cortés Vesga

1 joint publications

Moustafa Abohawya

1 joint publications

Lukas T Schmitt

1 joint publications

Daniel E Stange

Frequent Collaborators

3 joint publications

Frank Buchholz

1 joint publications

Maciej Paszkowski-Rogacz

1 joint publications

Michael Seifert

1 joint publications

Ingo Roeder

Top Related Videos

Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors

Published on : Feb 28, 2021

5.6K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on : Aug 25, 2017

7.9K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

3.3K
See more related videos

Top Related Videos

Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of <em>BRCA1</em> variants using CRISPR-Mediated Base Editors

Published on : Feb 28, 2021

5.6K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on : Aug 25, 2017

7.9K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on : Jun 17, 2022

3.3K
See more related videos